2010
DOI: 10.1038/bmt.2010.305
|View full text |Cite
|
Sign up to set email alerts
|

Cotransplantation of umbilical cord MSCs to enhance engraftment of hematopoietic stem cells in patients with severe aplastic anemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
31
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(31 citation statements)
references
References 10 publications
0
31
0
Order By: Relevance
“…1,36 On the one hand, the good responses to immunosuppressive treatments such as antithymocyte globulin and cyclosporine A support the belief that pathological T-cell-mediated autoimmune responses are a cause of the BM failure in AA. 1,34,36 On the other hand, several studies have shown that co-transplantation of allogeneic BM-or CB-derived MSC and HSC enhances hematopoietic engraftment and also improves stromal function in patients with AA, [37][38][39][40] suggesting a potential underlying role of the BM microenvironment in the pathogenesis of AA. In fact, AA patients have a hypocellular BM which is "physiologically" replaced by fatty BM, likely of mesenchymal origin, further supporting a potential contribution of the BM microenvironment to the pathogenesis of AA.…”
Section: Discussionmentioning
confidence: 99%
“…1,36 On the one hand, the good responses to immunosuppressive treatments such as antithymocyte globulin and cyclosporine A support the belief that pathological T-cell-mediated autoimmune responses are a cause of the BM failure in AA. 1,34,36 On the other hand, several studies have shown that co-transplantation of allogeneic BM-or CB-derived MSC and HSC enhances hematopoietic engraftment and also improves stromal function in patients with AA, [37][38][39][40] suggesting a potential underlying role of the BM microenvironment in the pathogenesis of AA. In fact, AA patients have a hypocellular BM which is "physiologically" replaced by fatty BM, likely of mesenchymal origin, further supporting a potential contribution of the BM microenvironment to the pathogenesis of AA.…”
Section: Discussionmentioning
confidence: 99%
“…All patients were aged <18 years; all underwent procedures of HSCT as previously reported. 9 The reduction of immunosuppressive agents were adjusted by the severity of graft-versushost disease (GVHD).…”
Section: Methodsmentioning
confidence: 99%
“…We found that BMMSCs derived from children with severe aplastic anemia exhibit poor potential of proliferation and differentiation [45]. Due to the possibility of BMMSC insufficiency, we cotransplanted UCMSCs along with HSCs in 2 children with severe aplastic anemia [4]. Both achieved faster hematopoietic engraftment without infusion-related toxicities.…”
Section: Clinical Application Of Mscs In Hsctmentioning
confidence: 99%
“…We share our clinical experience in the successful use of in vitro expanded UCMSCs [2–4]. We also describe several issues related to the clinical use of MSCs.…”
Section: Introductionmentioning
confidence: 99%